APA (7th ed.) Citation

Reiff, A., Krogstad, P., Moore, S., Shaham, B., Parkman, R., Kitchen, C., & Weinberg, K. (2009). Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy. Clinical Immunology, 133(3), 295. https://doi.org/10.1016/j.clim.2009.08.010

Chicago Style (17th ed.) Citation

Reiff, A., P. Krogstad, S. Moore, B. Shaham, R. Parkman, C. Kitchen, and K. Weinberg. "Study of Thymic Size and Function in Children and Adolescents with Treatment Refractory Systemic Sclerosis Eligible for Immunoablative Therapy." Clinical Immunology 133, no. 3 (2009): 295. https://doi.org/10.1016/j.clim.2009.08.010.

MLA (9th ed.) Citation

Reiff, A., et al. "Study of Thymic Size and Function in Children and Adolescents with Treatment Refractory Systemic Sclerosis Eligible for Immunoablative Therapy." Clinical Immunology, vol. 133, no. 3, 2009, p. 295, https://doi.org/10.1016/j.clim.2009.08.010.